DRUG · Unmapped registry intervention
Dermaprazole 1%
Find medicine records ·
Find other trials using this name
Clinical trial
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)
NCT05269160
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Dermaprazole 2%
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedTopical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Radiation Dermatitisverified · MONDO: radiodermatitis
Breast Cancerverified · MONDO: breast cancer
Interventions
Dermaprazole 1%DRUG
Dermaprazole 2%DRUG
Sponsors & collaborators
Baylor College of Medicinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05269160 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.